252 related articles for article (PubMed ID: 20333747)
1. Concise review: mind the gap: challenges in characterizing and quantifying cell- and tissue-based therapies for clinical translation.
Rayment EA; Williams DJ
Stem Cells; 2010 May; 28(5):996-1004. PubMed ID: 20333747
[TBL] [Abstract][Full Text] [Related]
2. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
Yim R
Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
[TBL] [Abstract][Full Text] [Related]
3. Scientific considerations for the regulatory evaluation of cell therapy products.
Petricciani J; Hayakawa T; Stacey G; Trouvin JH; Knezevic I
Biologicals; 2017 Nov; 50():20-26. PubMed ID: 28888427
[TBL] [Abstract][Full Text] [Related]
4. The translation of cell-based therapies: clinical landscape and manufacturing challenges.
Heathman TR; Nienow AW; McCall MJ; Coopman K; Kara B; Hewitt CJ
Regen Med; 2015; 10(1):49-64. PubMed ID: 25562352
[TBL] [Abstract][Full Text] [Related]
5. Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine.
Ratcliffe E; Thomas RJ; Williams DJ
Br Med Bull; 2011; 100():137-55. PubMed ID: 21852279
[TBL] [Abstract][Full Text] [Related]
6. Measuring the potency of a stem cell therapeutic.
Harper H; Rich IN
Methods Mol Biol; 2015; 1235():33-48. PubMed ID: 25388384
[TBL] [Abstract][Full Text] [Related]
7. Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.
Carmen J; Burger SR; McCaman M; Rowley JA
Regen Med; 2012 Jan; 7(1):85-100. PubMed ID: 22168500
[TBL] [Abstract][Full Text] [Related]
8. Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?
Loewenbrück K; Storch A
J Neurol; 2011 May; 258(Suppl 2):S346-53. PubMed ID: 21437664
[TBL] [Abstract][Full Text] [Related]
9. Specificity of Good Manufacturing Practice (GMP) for Biomedical Cell Products.
Tulina MA; Pyatigorskaya NV
Bull Exp Biol Med; 2018 Mar; 164(4):579-582. PubMed ID: 29504094
[TBL] [Abstract][Full Text] [Related]
10. Bench-to-bedside translation of stem cell therapies: where are we now and where are we going?
Martino G
Regen Med; 2016 Jun; 11(4):347-9. PubMed ID: 27188381
[No Abstract] [Full Text] [Related]
11. Prospects for translational regenerative medicine.
Chen FM; Zhao YM; Jin Y; Shi S
Biotechnol Adv; 2012; 30(3):658-72. PubMed ID: 22138411
[TBL] [Abstract][Full Text] [Related]
12. Improved harmonization of critical characterization assays across cell therapies.
Karanu F; Ott L; Webster DA; Stehno-Bittel L
Regen Med; 2020 May; 15(5):1661-1678. PubMed ID: 32589107
[TBL] [Abstract][Full Text] [Related]
13. GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy.
Aghayan HR; Goodarzi P; Arjmand B
Methods Mol Biol; 2015; 1283():93-107. PubMed ID: 25138723
[TBL] [Abstract][Full Text] [Related]
14. Good Manufacturing Practice (GMP) Translation of Advanced Cellular Therapeutics: Lessons for the Manufacture of Erythrocytes as Medicinal Products.
McGowan NWA; Campbell JDM; Mountford JC
Methods Mol Biol; 2018; 1698():285-292. PubMed ID: 29076098
[TBL] [Abstract][Full Text] [Related]
15. One, two, three steps toward cell therapy for stroke.
Diamandis T; Borlongan CV
Stroke; 2015 Feb; 46(2):588-91. PubMed ID: 25503552
[TBL] [Abstract][Full Text] [Related]
16. [Cell therapy for Parkinson's disease with induced pluripotent stem cells].
Morizane A
Rinsho Shinkeigaku; 2019 Mar; 59(3):119-124. PubMed ID: 30814448
[TBL] [Abstract][Full Text] [Related]
17. Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction.
Sheth-Shah R; Vernon AJ; Seetharaman S; Neale MH; Daniels JT
Regen Med; 2016 Apr; 11(3):307-20. PubMed ID: 26987030
[TBL] [Abstract][Full Text] [Related]
18. Media fill for validation of a good manufacturing practice-compliant cell production process.
Serra M; Roseti L; Bassi A
Methods Mol Biol; 2015; 1283():161-9. PubMed ID: 25096172
[TBL] [Abstract][Full Text] [Related]
19. Translating stem cell research from the bench to the clinic: a need for better quality data.
Plant AL; Parker GC
Stem Cells Dev; 2013 Sep; 22(18):2457-8. PubMed ID: 23597110
[TBL] [Abstract][Full Text] [Related]
20. Stem cell therapy for chronic heart failure: an updated appraisal.
Maltais S; Joggerst SJ; Hatzopoulos A; DiSalvo TG; Zhao D; Sung HJ; Wang X; Byrne JG; Naftilan AJ
Expert Opin Biol Ther; 2013 Apr; 13(4):503-16. PubMed ID: 23289619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
